Literature DB >> 15016061

Repair of complete atrioventricular septal defect with tetralogy of fallot: our experience and literature review.

Edvin Prifti1, Massimo Bonacchi, Massimo Bernabei, Marzia Leacche, Fabio Bartolozzi, Bruno Murzi, Francesco Battaglia, Nathan S Nadia, Vittorio Vanini.   

Abstract

OBJECTIVES: The aim of this report is to describe the rationale of our surgical approach, to explore the best management for complete atrioventricular septal defect associated with the tetralogy of Fallot (CAVSD-TOF), and to present our outcome in relation to the previously reported series.
MATERIALS AND METHODS: Between January 1990 and January 2002, 17 consecutive children with CAVSD-TOF underwent complete correction. Nine patients (53%) underwent previous palliation. Mean age at repair was 2.9 +/- 1.9 years. Mean gradient across the right ventricular outflow tract was 63 +/- 16 mmHg. All children underwent closure of septal defect with a one-patch technique, employing autologous pericardial patch. Maximal tissue was preserved for LAVV reconstruction by making these incisions along the RV aspect of the ventricular septal crest. LAVV annuloplasty was performed in 10 (59%) patients. Six patients (35%) required a transannular patch.
RESULTS: Three (17.6%) hospital deaths occurred in this series. Causes of death included progressive heart failure in two patients and multiple organ failure in the other patient. Two patients required mediastinal exploration due to significant bleeding. Dysrhythmias were identified in 4 of 11 patients undergoing a right ventriculotomy versus none of the patients undergoing a transatrial transpulmonary approach (p = ns). The mean intensive care unit stay was 3.2 +/- 2.4 days. Two patients required late reoperation due to severe LAVV regurgitation at 8.5 and 21 months, respectively, after the intracardiac complete repair. The mean follow-up time was 36 +/- 34 months. All patients survived and are in NYHA functional class I or II. The LAVV regurgitation grade at follow-up was significantly lower than soon after operation, 1.1 +/- 0.4 versus 1.7 +/- 0.5 (p = 0.002). At follow-up, the mean gradient across the right ventricular outflow tract was 17 +/- 6 mmHg, significantly lower than preoperatively (p < 0.001).
CONCLUSIONS: Complete repair in patients with CAVSD-TOF seems to offer acceptable early and mid-term outcome in terms of mortality, morbidity, and reoperation rate. Palliation prior to complete repair may be reserved in specific cases presenting small pulmonary arteries or severely cyanotic neonates. The RVOT should be managed in the same fashion as for isolated TOF; however, a transatrial transpulmonary approach is our approach of choice.

Entities:  

Mesh:

Year:  2004        PMID: 15016061     DOI: 10.1111/j.0886-0440.2004.04031.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  5 in total

1.  Repair of complete atrioventricular septal defect with tetralogy of Fallot.

Authors:  Edvin Prifti
Journal:  Transl Pediatr       Date:  2017-01

2.  Post-operative left atrioventricular valve function after the staged repair of complete atrioventricular septal defect with tetralogy of Fallot.

Authors:  Kazuki Morimoto; Takaya Hoashi; Koji Kagisaki; Kenichi Kurosaki; Isao Shiraishi; Hajime Ichikawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-05-07

3.  Tetralogy of Fallot with atrioventricular septal defect: surgical strategies for repair and midterm outcome of pulmonary valve-sparing approach.

Authors:  Umang Gupta; Anastasios C Polimenakos; Chawki El-Zein; Michel N Ilbawi
Journal:  Pediatr Cardiol       Date:  2012-10-27       Impact factor: 1.655

Review 4.  A review of the Nunn modified single patch technique for atrioventricular septal defect repair.

Authors:  Tracy R Geoffrion; Kanchana Singappuli; John S K Murala
Journal:  Transl Pediatr       Date:  2018-04

5.  Atrioventricular septal defect and tetralogy of Fallot - A single tertiary center experience: A retrospective review.

Authors:  Khaled A Alhawri; Colin J Mcmahon; Mohammed M Alrih; Yamin Alzein; Asad A Khan; Suhaib K Mohammed; Khaled S Alalwi; Kevin P Walsh; Damien P Kenny; Jonathon G McGuinness; Lars Nolke; John M Redmond
Journal:  Ann Pediatr Cardiol       Date:  2019 May-Aug
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.